ArticleCancer2019

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.

Joshua M Bauml et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.